Archon Partners LLC Neogenomics Inc Transaction History

Archon Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $765,299 - $1.22 Million	-25,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $120,813 - $152,308	-2,900 Reduced 10.36%	25,100 $1.21 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $223,381 - $315,309	6,100 Added 27.85%	28,000 $1.27 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $120,524 - $173,652	2,900 Added 15.26%	21,900 $1.06 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $685,520 - $1.07 Million	19,000 New	19,000 $1.02 Million

278

127M

581K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.86B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Archon Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Archon Partners LLC with notifications on news.